Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-03-13
2007-03-13
Page, Thurman (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S336000, C514S649000
Reexamination Certificate
active
11165293
ABSTRACT:
The present invention relates to a tetrafluorobenzyl derivative and a pharmaceutical composition for prevention and treatment of acute and chronic neurodegenerative disease in central nervous system and ophthalmic diseases containing the same. The tetrafluorobenzyl derivative of the present invention can effectively be used to prevent and treat chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease, degenerative brain disease such as epilepsy and ischemic brain disease such as stroke.
REFERENCES:
patent: 3632760 (1972-01-01), Shen et al.
patent: 3674844 (1972-07-01), Shen et al.
patent: 5434163 (1995-07-01), Edlind et al.
patent: 5527814 (1996-06-01), Louvel
patent: 6136835 (2000-10-01), Camden
patent: 6358945 (2002-03-01), Breitfelder et al.
patent: 2031227 (1971-01-01), None
patent: 122827 (1984-10-01), None
patent: 1268465 (1972-03-01), None
patent: 54-125632 (1979-09-01), None
patent: 60-237041 (1985-11-01), None
patent: 2000-212141 (2000-08-01), None
patent: 2000-273041 (2000-10-01), None
patent: WO 86/03199 (1986-06-01), None
patent: WO 94/13663 (1994-06-01), None
patent: WO 99/01421 (1999-01-01), None
Lehninger et al., Principles of Biochemistry, 2nd edition, 1993, pp. 384-390.
Beal, M. F. et al.,Nature, 321(6066):168-171 (1986).
Beal,Ann. Neurol., 38:357-366 (1995).
Benveniste, H et al.,J. Neurochem, 43(5):1369-1374 (1984).
Bush et al.,Science, 265:1464-1467 (1994).
Chan, P. H.J. Neurotrauma., 9 Suppl 2:S417-423 (1992).
Choi, D. W.,J. Neurosci., 7(2)357-367 (1987).
Choi, D. W.,Neuron, 1:623-634 (1988).
Choi, D. W. and Rothman, S. M.,Annu. Rev. Neurosci,. 13:171-182 (1990).
Dexter, D. T. et al.,Ann Neurol., 32 Suppl:S94-100 (1992).
Faden,Pharmacol. Toxicol., 78:12-17 (1996).
Fahn, S. and Cohen, g.,Ann. Neurol., 32(6):804-812 (1992).
Ferrante, R. J. et al.,Science, 230(4625):561-563 (1985).
Flamm, E. S. et al.,Stroke, 9(5):445-447 (1978).
Frederickson, C. J. and Bush, A. I.,Biometals, 14:353-366 (2001).
Goldberg, M. P. et al.J. Pharmac. Exp. Ther., 243:784-791 (1987).
Kogure, K. et al.,Prog. Brain Res., 64:237-259 (1985).
Koh, J. Y. et al.,Science, 234(4772):73-76 (1986).
Lee et al.,Proc. Natl. Acad. Sci., U.S.A. 99:7705-7710 (2002).
Olney, J. W. and Sharpe, L. G.,Science, 166:386-388 (1969).
Olney, J. W. and Ho, O. L.,Nature, 227(258):609-611 (1970).
Olney, J. W.Int. Rev. Neurobiol., 27:337-362 (1985).
Olney et al.,Science, 244:1360-1362 (1989).
Rosen et al.,Nature362:59-62 (1993).
Rothstein, J. D.,Clin. Neurosci., 3(6):348-359 (1995).
Schapira, A. H.,Curr. Opin. Neurol., 9(4)260-264 (1996).
Schubert, D. et al.,Proc. Natl. Acad. Sci., U.S.A. 92(6):1989-1993 (1995).
Shaw, P. J. and Ince, P. G.,J. Neurol., 244 Suppl 2:S3-14 (1997).
Sheardown, M. J. et al,Science, 247:571-574 (1990).
Siegel G. J. et al.,Basic Neurochemistry, 6thedition, Lippincott Williams & Wilkins, 315-333 (1999).
Simon et al.,Science, 226:850-852 (1984).
Sofic, E. et al.,J. Neurol Transm., 74:199-205 (1988).
Suh et al.,Brain Res., 852:274-278 (2000).
Weiss et al.,Trend. Pharmacol. Sci. 21:395-401 (2001).
Benveniste, H et al.,J. Neurochem, 43(5):1369-1374 (1984).
Chan, P. H.J. Neurotrauma., 9 Suppl 2:S417-423 (1992).
Dexter, D. T. et al.,Ann Neurol., 32 Suppl:S94-100 (1992).
Fahn, S. and Cohen, G.,Ann. Neurol., 32(6):804-812 (1992).
Ferrante, R. J. et al.,Science, 230(4625):561-563 (1985).
Flamm, E. S. et al.,Stroke, 9(5):445-447 (1978).
Frederickson, C. J. and Bush, A. I.,Biometals, 14:353-366 (2001).
Goldberg, M. P. et al.J. Pharmac. Exp. Ther., 243:784-791 (1987).
Kogure, K. et al.,Prog. Brain Res., 63:237-259 (1985).
Lee et al.,Proc. Natl. Acad. Sci., U.S.A. 99:7705-7710 (2002).
Olney et al.,Science, 244:1360-1362 (1989).
Olney, J. W. and Ho, O. L.,Nature, 227(258): 609-611 (1970).
Olney, J. W. and Sharpe, L. G.,Science, 166:386-388 (1969).
Olney, J. W.Int. Rev. Neurobiol., 27:337-362 (1985).
Schapira, A. H.,Curr. Opin. Neurol., 9(4)260-264 (1996).
Schubert, D. et al.,Proc. Natl. Acad. Sci., U.S.A. 92(6):1989-1993 (1995).
Shaw, P. J. and Ince, P. G.,J. Neurol., 244 Suppl 2:S3-14 (1997).
Sheardown, M. J. et al.,Science, 247:571-574 (1990).
Siegel G. J. et al.,Basic Neurochemistry, 6thedition, Lippincott Williams & Wilkins, 315-333 (1999).
Sofic, E. et al.,J. Neural Transm., 74:199-205 (1988).
Weiss et al.,Trend. Pharmacol., Sci. 21:395-401 (2001).
Anderson, D.K. et al., Ann. Emerg. Med. 22:987-992 (1993).
Anderson, W.W. et al., J. Neurophysiol. 57:1-21 (1987).
Beal, M.F., Ann. Neurol. 38:357-366 (1995).
Beal, M.F. et al, J.Neurosci. 11:1649-1659 (1991).
Beal, M.F. et al., Nature 321: 168-171 (1986).
Brouillet, E. et al.. Neuroreport. 4:387-390 (1993).
Browne, S.E. et al., Brain Pathol. 9:147-163 (1999).
Bush, A.I. et al., Science 265:1464-1467 (1994).
Chan, P.H., Stroke 27:1124-1129 (1996).
Choi, D.W. et al., Annu Rev Neurosci 13:171-182 (1990).
Choi, D.W. et al., Journal of Neuroscience 7(2):357-368 (1987).
Choi, D.W. et al., J Neurosci. 7:369-379, 1987).
Choi, D.W., Neuron 1:623-634 (1988).
Choi, D.W. et al., Annu. Rev. Neursci 21:347-375 (1988).
Cuajungco, M.P. et al., Brain Research Reviews 23:219-236 (1997).
Demediuk, P. et al., J. Neurochem. 52:1529-1536 (1989).
Dingledine, R. et al., Trends Pharmacol. Sci. 11:334-338 (1990).
Sinz, E.H. et al, J. of Cerebral Blood Flow and Metabolism 18:610-615 (1998).
Eisen, A. et al., Drugs Aging 14:173-196 (1999).
Faden, A.I. et al, Science 244:798-800 (1989).
Faden, A.I. et al., J. Neurotrauma. 5:33-45 (1988).
Faden, A.I., Pharmacol. Toxicol. 78:12-17 (1996).
Fischer-Nielsen, A. et al.,Free Radic Biol Med. 13(2): 121-126 (1992).
Frederickson, C.J. et al., Brain Res. 480:317-321 (1989).
Gerlach, M. et al.,Journal of Neurochemistry63: 793-807 (1994).
Gilgun-Sherki, Y. et al.,Pharmacological Reviews54: 271-284 (2002).
Goldberg, M.P. et al., J Neurosci. 13:3510-3524 (1993).
Goodman & Gilman's The Pharmacological Basis of Therapeutics, Joel G. Hardman et al., eds., 9.sup.th edition, 1996, The McGraw-Hill Companies, pp. 617-631 & 1059-1062.
Grisham, M.B. et al.,Dig. Dis Sci. 37(9): 1383-1389 (1992).
Grundman, M., Am.J.Clin.Nutr. 71:630S-636S (2000).
Gwag, BJ et al., Neuroscience. 68:615-619 (1995).
Hall, E.D. et al., J. of Neurotrauma. 5:81-89 (1988).
Hall, E.D. et al., Free Radic.Biol.Med. 6:303-313 (1989).
Hall, E.D., Neurosurg.Clin.N.Am. 8:195-206 (1997).
Holmes, G.L. et al., Cleve. Clin. J. Med. 72:240-247 (1995).
Hussain, F.N. et al.,Br J. Clin Pharmacol. 49(4): 323-330, Apr. 2000.
Ikonomidou, C, et al., J. Neuropathol. Exp. Neurol. 55:211-224 (1996).
International Preliminary Examination Report for PCT/KR 00/00366, Aug. 23, 2002.
Jenner, and Olanow, Neurology 47:S161-S170 (1996).
Jenner, P., Pathol. Biol. (Paris.) 44:57-64 (1996).
Joo, C-K. et al, Investigative Ophthalmology & Visual Science 40:713-720 (1999).
Kass, I.S. et al., Exp. Neurol. 103:116-122 (1989).
Kim, E.Y. et al, European Journal of Neuroscience, 11:327-334 (1999).
Klotz, et al.,Arzneimittel-Forschung. Drug Research43(12): 1357-1359, Dec. 1993.
Koh, J.Y. et al., J Neurosci Methods 20:83-90 (1987).
Koh, J.Y. et al., Science 234:73-76 (1986).
Koh, J.Y. et al., Science 272: 1013-1016 (1996).
Kumamoto, T. et al.,Jpn. J. Pharmacol. 75: 187-189, 1997.
Lakowski, B. et al., Science 272: 1010-1013 (1996).
Lange, K.W. et al., Naunyn Schmiedebergs Arch.Pharmacol. 348(6):586-592 (1993).
Lee, J-M et al., Nature 399:A7-A14 (1999).
Love, S., Brain Pathol. 9:119-131 (1999).
Marin, C. et al., Brain Res. 736:202-205 (1996).
McNamara, J.O. et al., Neuropharmacology 27:563-568 (1988).
Merello, M. et al., Clin. Neuropharmacol. 22:273-276 (1999).
Minta, A. et al., Journal of Biological Chemistry 264(14):8171-8178 (1989).
Montastruc, J.L. et al, Neuroscience and Biobehavioral Reviews 21(4):477-480 (1997).
Mysyk, D. D. et al., “Chloromethylation of 4-arenesulfonyl-N-methylamidoanisoles,” Soviet Progress in Chemistry. 33(2), 59-62 (1967).
Nussbaumer, P. et al., “Novel Antiproliferative Agents Derived from Lavendustin A,” J. Med. Chem. 37(24) 4079-84 (1994).
Spector, R. et al.,J. Pharmacol. Exp. Ther. 188: 55-65
Gwag Byoung-Joo
Lee Hae-Un
Lee Young-Ae
Moon Ho-Sang
Park Eun-Chan
Neurotech Co., Ltd.
Page Thurman
Puttlitz Karl
Seed IP Law Group PLLC
LandOfFree
Tetrafluorobenzyl derivatives and pharmaceutical composition... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrafluorobenzyl derivatives and pharmaceutical composition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrafluorobenzyl derivatives and pharmaceutical composition... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3782156